Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $104.26 million
- Book Value:
- Revenue TTM:
- $27.66 million
- Operating Margin TTM:
- Gross Profit TTM:
- $14.01 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
DarioHealth Corp had its IPO on 2014-10-06 under the ticker symbol DRIO.
The company operates in the Healthcare sector and Diagnostics & Research industry. DarioHealth Corp has a staff strength of 241 employees.
Shares of DarioHealth Corp opened at $3.92 at the start of the last trading session i.e. 2023-03-19.
The stocks traded within a range of $3.87 - $4.08, and closed at $4.03.
This is a 0% increase from the previous day's closing price.
A total volume of 162,700 shares were traded at the close of the day’s session.
In the last one week, shares of DarioHealth Corp have slipped by -9.23%.
DarioHealth Corp's Key Ratios
DarioHealth Corp has a market cap of $104.26 million, indicating a price to book ratio of 1.1263 and a price to sales ratio of 3.4241.
In the last 12-months DarioHealth Corp’s revenue was $27.66 million with a gross profit of $14.01 million and an EBITDA of $-52093000. The EBITDA ratio measures DarioHealth Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, DarioHealth Corp’s operating margin was -205.42% while its return on assets stood at -32.28% with a return of equity of -75.14%.
In Q4, DarioHealth Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 13%.
DarioHealth Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-2.43 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into DarioHealth Corp’s profitability.
DarioHealth Corp stock is trading at a EV to sales ratio of 2.5387 and a EV to EBITDA ratio of -1.0225. Its price to sales ratio in the trailing 12-months stood at 3.4241.
DarioHealth Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $119.19 million
- Total Liabilities
- $19.35 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
DarioHealth Corp ended 2023 with $119.19 million in total assets and $0 in total liabilities. Its intangible assets were valued at $119.19 million while shareholder equity stood at $80.00 million.
DarioHealth Corp ended 2023 with $910000.00 in deferred long-term liabilities, $19.35 million in other current liabilities, 3000.00 in common stock, $-285850000.00 in retained earnings and $41.64 million in goodwill. Its cash balance stood at $49.36 million and cash and short-term investments were $49.36 million. The company’s total short-term debt was $293,000 while long-term debt stood at $18.11 million.
DarioHealth Corp’s total current assets stands at $65.52 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $6.42 million compared to accounts payable of $2.32 million and inventory worth $7.96 million.
In 2023, DarioHealth Corp's operating cash flow was $-59000.00 while its capital expenditure stood at $398999.56.
Comparatively, DarioHealth Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
DarioHealth Corp stock is currently trading at $4.03 per share. It touched a 52-week high of $7.692 and a 52-week low of $7.692. Analysts tracking the stock have a 12-month average target price of $12.75.
Its 50-day moving average was $5.09 and 200-day moving average was $5.1 The short ratio stood at 12.59 indicating a short percent outstanding of 0%.
Around 1815.8% of the company’s stock are held by insiders while 3093.9% are held by institutions.
Frequently Asked Questions About DarioHealth Corp
Similar Industry Stocks (Diagnostics & Research)
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.